Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice

NCT02655159 · clinicaltrials.gov ↗
TERMINATED
Status
46
Enrollment
INDUSTRY
Sponsor class

Stopped Given the infeasibility to achieve the study population together with the loss of originality in the scientific rationale, it was considered to cancel the study

Conditions

Sponsor

Celgene Corporation